About the Resource
Collaborations
The collaborative Resource projects on the following list were selected based on their capacity to benefit from the Resource's capabilities, their scientific and biomedical relevance, and their ability to challenge the core technology and specific technological aims within the Resource:
NCRR Proteomics Data Standards and Informatics Tools
Phil Andrews, Ph.D.
Andrews Research Laboratory
Biological Chemistry
University of Michigan, Ann Arbor, Michigan
Developing scFv Antibody Reagents to Quantify Signaling Molecules in the Yeast Pheromone Response Pathway
Roger Brent, Ph.D.
Molecular Sciences Institute, Berkeley, California
Trauma-Induced Reprogramming: Changes in Lipid Raft Protein Content
Joseph Cuschieri, Ph.D.
Department of Surgery
University of Washington, Seattle, Washington
Study of Secretory and Membrane Proteins of Pseudomonas aeruginosa
Ronald W. Davis, Ph.D.
Stanford University School of Medicine
Stanford University , Stanford, California
The Use of Novel Proteomics in the Plasma and Tumor Microenvironment for Class Prediction in Human Breast Cancer
Stephen R. Grobmyer, Ph.D.
Department of Surgery
University of Florida, Gainesville, Florida
Cellular Response to Hepatitus C Virus Infection: Global Quantitative Proteome AMT Tag Measurements of Cellular Protein Expression
Michael G. Katze, Ph.D.
University of Washington, Seattle, Washington
Michael Katze laboratory
National Institute on Drug Abuse Center for Functional Genomics and HCV-Associated Liver disease
Primate Genomics Division, part of the Washington National Primate Research Center
Characterization of the Tumor Cell Lamellipoda Phosphoproteome AND
Characterization of the Neurite Phosphoproteome
Richard Klemke, Ph.D.
University of California, San Diego Medical Center , San Diego, California
Characterization of the SATB1 Phosphorylations upon Ionization Radiation
Terumi Kohwi-Shigematsu, Ph.D.
Lawrence Berkeley National Laboratory, Berkeley, CA
Pilot Study on Examination of LIRKO Islets and Serum Using Quantitative Proteomic Approaches
Rohit N. Kulkarni, M.D., Ph.D.
Joslin Diabetes Center
Harvard Medical School, Boston, Massachusetts
A Proteome for Specific Cell Types in Caenorhabditis elegans
Donald G. Moerman, Ph.D.
Department of Zoology
University of British Columbia, Vancouver, B.C.
Proteomic Investigation of HCMV and the Characterization of Specific Viral Protein-Host Protein Interactions
Jay A. Nelson, Ph.D.
Department of Molecular Biology and Immunology
Oregon Health Sciences University Vaccine, and Gene Therapy Institute, Portland, Oregon
Membrane Proteomics of Breast Cancer Cell Lines
Maria G. Pallavicini, Ph.D.
School of Natural Sciences
University of California, Merced, California
Substrate Identification for Ser/Thr Protein Phosphatase AND
Identification of Protein Phosphatase 5 Targes in the DNA Damage Response Pathway
Sandra S. Rossie, Ph.D.
Department of Biochemistry
Perdue University, West Lafayette, Indiana
Preliminary Work on the Proteomes of Brains Obtained from Control Mice and Treated Mice Simulating Parkinson's Disease
Desmond J. Smith, M.D., Ph.D.
Department of Molecular and Medical Pharmacology
UCLA School of Medicine, Los Angeles, California
Identification of Post-Translational Modifications and Protein Complexes Under Conditions of Oxidative Stress AND
Reactive Oxygen and Nitrogen Species, Produce Dynamic Protein Modifications and Protein Complexes in RAW 264.7 Macrophage Cells
Thomas C. Squier, Ph.D.
Pacific Northwest National Laboratory, Richland, Washington
Identification and Post-translational Modification of Mitotic Regulatory Proteins
David L. Stenoien, Ph.D.
Pacific Northwest National Laboratory, Richland, Washington
Proteomic Analysis of the HMEC Mitogenic Response
Brian D. Thrall, Ph.D.
Pacific Northwest National Laboratory, Richland, Washington
High Resolution Mass Spectrometric Identification of Bacterial Membrane Proteins in Gram-negative Sepsis
Ronald G. Tompkins, M.D., Sc.D.
Department of Surgery
Massachusetts General Hospital, Boston, Massachusetts
Proteomic Characterization of Cerebrospinal Fluid (CSF) by High Resolution LC-MS/MS
H. Shaw Warren, M.D.
Massachusetts General Hospital East and Harvard University School of Medicine, Charlestown, Massachusetts
Translation Repressor, 4E-BP2, is Covalently Modified in the Mammalian Brain
Nahum Sonenberg, Ph.D.
Department of Biochemistry, McGill University, Canada.
Tamoxifen-Resistant Breast Cancer Profiled by Advanced LC-MS
Arzu Umar
Erasmus MC
University Medical Center Rotterdam, The Netherlands
Large Scale Analysis of Ras Family Small Gtpase Signaling
Mark H. Ginsberg
Department of Medicine
University of California, San Diego, California.
Burn Injury Induced Changes in Protein Expression by Circulating T Cells
John A. Mannick
Department of Surgery
Harvard Medical School, Boston, Massachusetts